Conor McNamara Stock Analyst Profile - RBC Capital Research Coverage - Stocknear

Conor McNamara

Stock Analyst at RBC Capital

(2.81)
# 3057
Out of 5,470 analysts
125
Total ratings
Success rate
Average return
14 Stocks
Name Action PT Current % Upside Ratings Updated
TECH Bio-Techne
Upgrades: Outperform
61 73
53.62 36.14% 11 Sep 3, 2025
MRVI Maravai LifeSciences
Maintains: Outperform
7 5
2.46 103.25% 7 Aug 12, 2025
NTRA Natera
Maintains: Outperform
251 255
167.37 52.36% 2 Aug 8, 2025
OABI OmniAb
Maintains: Outperform
4 3
1.57 91.08% 4 Aug 7, 2025
EXAS Exact Sciences
Maintains: Sector Perform
54 46
53.5 -14.02% 1 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
72 87
66.18 31.46% 12 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 17
13.12 29.57% 9 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
118 126
97.62 29.07% 16 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
387 409
287.62 42.2% 12 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
193 204
119.96 70.06% 12 Jul 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
651 637
484.22 31.55% 14 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
250 250
197.34 26.68% 10 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
64 61
28.28 115.7% 11 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 7
3.4 105.88% 4 Aug 7, 2024